Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
TBK1 and Microglial Pyroptosis in Diabetic Neuropathy
2026-08-29
Liao et al. identify TANK-binding kinase 1 (TBK1) as a mechanistic driver of painful diabetic neuropathy by linking its activation in spinal microglia to NF-κB signaling, NLRP3 inflammasome activity, and pyroptotic cell death. Genetic silencing and pharmacological inhibition of TBK1 reduced neuropathic pain-related phenotypes and peripheral nerve injury in diabetic mouse models, supporting TBK1 as a tractable neuroinflammatory target.
-
Halazone: Designing Redox-Aware Dual Assays
2026-08-28
Halazone is an antimicrobial sulfonamide derivative whose value extends from rapid water disinfection to mechanistic sodium-current research. This guide explains how redox conditions, formulation stability, and assay design determine whether those two applications generate interpretable data.
-
Sumatriptan as an Anti-Inflammatory Agent
2026-08-28
Ala and colleagues synthesized evidence that sumatriptan may regulate inflammation beyond its established role in migraine treatment, linking 5-HT1B/1D signaling with cytokines, nitric oxide, CGRP, and cell-survival pathways. The review is especially useful as a hypothesis-generating framework for interpreting preclinical anti-inflammatory findings, while its heterogeneous evidence base limits direct clinical translation.
-
CFDA-SE for Proliferation and Surface-Biology Assays
2026-08-27
CFDA-SE converts division history into a measurable fluorescence pattern, supporting lymphocyte, fibroblast, NK-cell, and bacterial proliferation studies. When paired thoughtfully with CD38 surface-proximity mapping, it helps distinguish changes caused by cell division from changes in adhesion, migration, or membrane organization.
-
How IPA Controls TAA1 in Auxin Biosynthesis
2026-08-27
The 2022 PNAS study identifies indole-3-pyruvic acid (IPyA) as a feedback regulator of the tryptophan aminotransferase TAA1, resolving how the two-step auxin pathway coordinates precursor production with IAA formation. Its enzymology, chemical genetics, and cross-species evidence provide a framework for interpreting IPA-dependent changes in plant hormone research and designing more informative auxin biosynthesis assays.
-
Streptavidin-HyperFluor 647: Workflow Guide
2026-08-26
Streptavidin-HyperFluor 647 combines high-affinity biotin recognition with red-shifted fluorescence for sensitive imaging, flow cytometry, and biotinylated antibody detection. This guide explains how to deploy it reliably while distinguishing conventional biotin readouts from newer biotin-free proximity-labeling platforms.
-
SmD2 Acetylation Rewires HCC PARP Sensitivity
2026-08-26
A 2024 Nature Communications study identifies SmD2 acetylation as a regulatory link between core spliceosome function, BRCA1/FANC cassette-exon selection, DNA damage repair, and PARP inhibitor response in hepatocellular carcinoma. The findings support a preclinical strategy that combines HDAC-axis modulation with PARP inhibition, while emphasizing the need to validate spliceosome-dependent drug sensitivity across tumor models.
-
Plk1 Control of p31comet in Mitotic Checkpoint Exit
2026-08-25
The 2019 PNAS study identifies Polo-like kinase 1 (Plk1) as a negative regulator of p31comet-mediated mitotic checkpoint complex disassembly. Its biochemical, inhibitor-based, and mutational evidence supports a model in which Plk1 phosphorylation of p31comet at S102 suppresses premature checkpoint inactivation during mitosis.
-
Cyclic di-GMP: A Decision Guide for Dual-Context Research
2026-08-25
Cyclic di-GMP is an intracellular second messenger whose effects depend on biological context, timing, and assay design. This guide translates recent antitoxin research into practical strategies for biofilm persistence studies while defining the boundaries of STING-focused immune modulation research.
-
TBST for Cleaner Antibody Assays
2026-08-24
TBST combines buffered isotonic conditions with Tween 20 to reduce nonspecific binding across Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. This guide translates that chemistry into practical workflows, assay controls, and troubleshooting strategies relevant to metastasis-focused research.
-
C34: A TLR4 Benchmark for Assay Design
2026-08-24
C34 is a selective TLR4 inhibitor for converting inflammatory pathway observations into testable causal evidence. This article presents an assay-centered framework linking macrophage, enterocyte, and neuroinflammation models while clarifying what the Taxus chinensis study does—and does not—prove.
-
Vincristine Sulfate: Workflow & Assay Guide
2026-08-23
Build more reproducible cancer research workflows with vincristine sulfate by connecting microtubule-based mechanism, dose–response design, and orthogonal validation. This guide translates product specifications and systematic-review methodology into practical cell-based, xenograft, and troubleshooting strategies.
-
MK 0893: Mechanism-to-Assay Guide
2026-08-22
Explore MK 0893, a glucagon receptor antagonist, through an assay-first lens that connects allosteric receptor control with cAMP pharmacology, selectivity testing, and translational diabetes models.
-
Ferrostatins and Oxidative Lipid Damage
2026-08-22
The reference study established ferrostatin-1 as a potent inhibitor of ferroptosis that acts by suppressing oxidative damage to membrane lipids rather than broadly eliminating all cellular reactive oxygen species. Its cross-model experiments connected lipid peroxidation with cell death in Huntington’s disease, periventricular leukomalacia, and kidney dysfunction models, while its chemical analysis guided the design of improved ferrostatins.
-
DeferoxamineB in Cancer Research
2026-08-21
Deferoxamine, also called DeferoxamineB, is an Fe(III)-chelating research compound for studying iron availability, oxidative stress, and regulated cell death. Its strongest experimental value is as an iron-axis perturbation tool, not as a standalone proof of ferroptosis, cuproptosis, apoptosis, or autophagy.